Samuel D Vasikaran

7.0k total citations · 1 hit paper
120 papers, 5.0k citations indexed

About

Samuel D Vasikaran is a scholar working on Orthopedics and Sports Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Samuel D Vasikaran has authored 120 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Orthopedics and Sports Medicine, 42 papers in Oncology and 27 papers in Molecular Biology. Recurrent topics in Samuel D Vasikaran's work include Bone health and osteoporosis research (43 papers), Bone health and treatments (41 papers) and Bone Metabolism and Diseases (18 papers). Samuel D Vasikaran is often cited by papers focused on Bone health and osteoporosis research (43 papers), Bone health and treatments (41 papers) and Bone Metabolism and Diseases (18 papers). Samuel D Vasikaran collaborates with scholars based in Australia, United Kingdom and Belgium. Samuel D Vasikaran's co-authors include John А. Kanis, Cyrus Cooper, Eugène McCloskey, Howard A. Morris, Richard Eastell, Tommaso Trenti, Andrea Griesmacher, J. A. Kanis, Leon Flicker and Intan Nureslyna Samsudin and has published in prestigious journals such as The Lancet, Circulation and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Samuel D Vasikaran

117 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: a need for international reference standards

2010 865 citations Samuel D Vasikaran, Richard Eastell et al. profile →

Peers

Samuel D Vasikaran

OSM

ONCOL

SURGE

PFM

Giancarlo Isaia Italy

Robert A. Adler United States

M. Carola Zillikens Netherlands

Gregory D. Gamble New Zealand

Hiroshi Hagino Japan

Stephen P. Heyse United States

Steven M. Petak United States

Deborah E. Sellmeyer United States

Harald Dobnig Austria

Johan G. Brun Norway

Giancarlo Isaia Italy

Samuel D Vasikaran

1.9k ×0.8

OSM

1.7k ×1.1

ONCOL

1.8k ×1.7

700 ×0.8

SURGE

707 ×0.8

PFM

Citations per year, relative to Samuel D Vasikaran Samuel D Vasikaran (= 1×) peers Giancarlo Isaia

Countries citing papers authored by Samuel D Vasikaran

Since Specialization

Citations

This map shows the geographic impact of Samuel D Vasikaran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Samuel D Vasikaran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Samuel D Vasikaran more than expected).

Fields of papers citing papers by Samuel D Vasikaran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Samuel D Vasikaran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Samuel D Vasikaran. The network helps show where Samuel D Vasikaran may publish in the future.

Co-authorship network of co-authors of Samuel D Vasikaran

This figure shows the co-authorship network connecting the top 25 collaborators of Samuel D Vasikaran. A scholar is included among the top collaborators of Samuel D Vasikaran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Samuel D Vasikaran. Samuel D Vasikaran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cavalier, Étienne, Harjit Pal Bhattoa, Annemieke C. Heijboer, et al.. (2025). Assessment of measurement uncertainty of immunoassays and LC-MS/MS methods for serum 25-hydroxyvitamin D. Clinical Chemistry and Laboratory Medicine (CCLM). 63(10). 1981–1991. 2 indexed citations

Vasikaran, Samuel D, Konstantinos Makris, Harjit Pal Bhattoa, et al.. (2025). The importance of laboratory medicine in the management of CKD-MBD: insights from the KDIGO 2023 controversies conference. Clinical Chemistry and Laboratory Medicine (CCLM). 63(12). 2371–2376. 1 indexed citations

Chubb, S. A. Paul & Samuel D Vasikaran. (2025). Proposed common reference intervals for reference bone turnover markers in osteoporosis. Pathology. 58(2). 181–188.

Vasikaran, Samuel D, et al.. (2023). The Use of Bone-Turnover Markers in Asia-Pacific Populations. Annals of Laboratory Medicine. 44(2). 126–134. 10 indexed citations

Chubb, S. A. Paul, Samuel D Vasikaran, & Melissa J Gillett. (2023). Reference intervals for plasma β-CTX and P1NP in children: A systematic review and pooled estimates. Clinical Biochemistry. 118. 110582–110582. 13 indexed citations

Cavalier, Étienne, Callum G. Fraser, Harjit Pal Bhattoa, et al.. (2023). Analytical performance specifications for the measurement uncertainty of 24,25-dihydroxyvitamin D examinations. Clinical Chemistry and Laboratory Medicine (CCLM). 61(9). 1561–1566. 4 indexed citations

Brown, Jacques P., Andrew Don-Wauchope, Pierre Douville, Caroline Albert, & Samuel D Vasikaran. (2022). Current use of bone turnover markers in the management of osteoporosis. Clinical Biochemistry. 109-110. 1–10. 67 indexed citations

Cavalier, Étienne, Richard Eastell, Niklas Rye Jørgensen, et al.. (2021). A Multicenter Study to Evaluate Harmonization of Assays for C-Terminal Telopeptides of Type I Collagen (ß-CTX): A Report from the IFCC-IOF Committee for Bone Metabolism (C-BM). Calcified Tissue International. 108(6). 785–797. 12 indexed citations

Vasikaran, Samuel D & Tze Ping Loh. (2021). Interpretative commenting in clinical chemistry with worked examples for thyroid function test reports. Practical Laboratory Medicine. 26. e00243–e00243. 3 indexed citations

10.

Vasikaran, Samuel D, Masakazu Miura, Richard Pikner, Harjit Pal Bhattoa, & Étienne Cavalier. (2021). Practical Considerations for the Clinical Application of Bone Turnover Markers in Osteoporosis. Calcified Tissue International. 112(2). 148–157. 44 indexed citations

11.

Vasikaran, Samuel D. (2014). Anatomy and history of an external quality assessment program for interpretative comments in clinical biochemistry. Clinical Biochemistry. 48(7-8). 467–471. 10 indexed citations

12.

Fatovich, Daniel M, et al.. (2011). Correlation of paired toxic plasma and saliva paracetamol concentrations following deliberate self‐poisoning with paracetamol. British Journal of Clinical Pharmacology. 74(1). 154–160. 4 indexed citations

13.

Fatovich, Daniel M, et al.. (2010). Ischaemia modified albumin cannot be used for rapid exclusion of acute coronary syndrome. Emergency Medicine Journal. 27(9). 668–671. 7 indexed citations

14.

Vasikaran, Samuel D. (2008). Utility of Biochemical Markers of Bone Turnover and Bone Mineral Density in Management of Osteoporosis. Critical Reviews in Clinical Laboratory Sciences. 45(2). 221–258. 77 indexed citations

15.

Flicker, Leon, Ralph N. Martins, Jenny Thomas, et al.. (2006). B-vitamins reduce plasma levels of beta amyloid. Neurobiology of Aging. 29(2). 303–305. 39 indexed citations

16.

Almeida, Osvaldo P., et al.. (2005). A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: Effect on mood, cognition and quality of life. Neurobiology of Aging. 27(1). 141–149. 92 indexed citations

17.

Burnett, John R., Kevin D. Croft, Andrew J. Brown, et al.. (2001). Clinical and biochemical features, molecular diagnosis and long-term management of a case of cerebrotendinous xanthomatosis. Clinica Chimica Acta. 306(1-2). 63–69. 24 indexed citations

18.

Vasikaran, Samuel D. (2001). Bisphosphonates: an overview with special reference to alendronate. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 38(6). 608–623. 96 indexed citations

19.

Burnett, John R., John B. Blennerhassett, W. B. McConnell, et al.. (2000). Therapeutic efficiency of tirofiban in acute coronary syndromes (multiple letters). The Lancet. 355(9207). 929–931. 3 indexed citations

20.

Panegyres, Peter K., Cyril Mamotte, Samuel D Vasikaran, et al.. (1999). Butyrylcholinesterase K variant and Alzheimer's disease. Journal of Neurology. 246(5). 369–370. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact